Inhibition of Trmt6 resulted in decreased proliferation in glioma cell lines, establishing a potential oncogenic role for TRMT6 in regulating proliferation (Macari et al., 2016; Wang B. et al., 2021). This evidence concerns the gene TRMT6 and central nervous system cancer.